Most elective and non-urgent surgeries were halted in its hospitals for several weeks due to the pandemic from mid-March but have since restarted, though the FTSE 250 group said its results were still in line with expectations for its Southern Africa and Swiss businesses, while the Middle East was hit by the macroeconomic environment and increased competition.
Reported losses before tax doubled to £315mln after further write-downs were made to goodwill for its Middle East arm, with a £10mln impairment charge for its 29.9% stake in UK private hospital operator Spire Healthcare.
Group revenues rose 5% to £3.1bn from a balance of organic growth and incremental acquisitions.
The board took the decision to suspend the dividend in April and said it will keep this position under review.
Chief executive Ronnie van der Merwe said the group had made strong operational progress and was preparing for a range of eventualities from the impact of coronavirus.
Published at Tue, 02 Jun 2020 06:50:00 +0000-Mediclinic losses double after Middle East write-downs